London Social Venture Fund
London universities team up to support new startups with a social purpose. Social ventures emerging from a university’s knowledge base have...
Boosted by $3 million in seed funding, Queen Mary spin-out heralds developments in cancer immunotherapies and a vision of immune system stimulation
Boosted by $3 million in seed funding, Queen Mary spin-out heralds developments in cancer immunotherapies and a vision of immune system...
Queen Mary University of London spin-off provides the blueprint for new game-changing AI applications
Queen Mary University of London spin-off provides the blueprint for new game-changing AI applications Veritone, Inc. has acquired the video...
Blizard Institute spinout company Enterika Ltd secures funding from Queen Mary Investment Fund
Blizard Institute spinout company Enterika Ltd secures funding from Queen Mary Investment FundQueen Mary Innovation, the university’s technology...
Queen Mary appoints Phil Clare as CEO of Queen Mary Innovation
Queen Mary appoints Phil Clare as CEO of Queen Mary InnovationDr Clare will drive knowledge exchange and commercialisation of Queen Mary’s...
Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selectionrsity of London
Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for...
Contact QMI
If you would like to find out more information about our technologies or have any queries, please contact the relevant team member using our contact information found on our team profiles.